Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenshao tablet for exercise tolerance in chronic ischemic heart failure
ChiCTR2100042242Phase 4Recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Mar 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Shenshao tablet in ischaemic cardiomyopathy (ICM) (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Veterans Specific Activity Questionnaire (VSAQ). Started Mar 2021; status: recruiting.
02
Drugs
Shenshao tablet
03
Conditions
ischaemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on ChiCTR2100042242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042242.